Last mentioned: Mar 25, 2026
Charles Schwab reported record-breaking 2025 results with $12 trillion in client assets and a 50% surge in adjusted EPS, signaling a powerful recovery in the brokerage sector. Conversely, life sciences firm MaxCyte is navigating a 15% revenue decline as cell therapy customers consolidate programs and reduce capital expenditures.
MaxCyte reported a 15% revenue decline for 2025, driven by the loss of six clinical programs and reduced spending from its largest customer. Despite these headwinds, the company expanded its installed base to 857 units and significantly improved gross margins through aggressive cost-cutting measures.
Wealth Enhancement Advisory Services LLC (WEAS) increased its position in the Schwab U.S. Large-Cap Growth ETF (SCHG) by 0.8% during the fourth quarter. This acquisition brings the firm's total holdings to over 3.1 million shares, signaling a sustained institutional appetite for low-cost, growth-oriented equity exposure.
Short interest in the Schwab US Small-Cap ETF (SCHA) has declined by 24.5%, signaling a significant reduction in bearish sentiment. This shift suggests that investors are covering short positions as the risk-reward profile for small-cap equities becomes more attractive.
Eric Trump, co-founder of World Liberty Financial, has reaffirmed his long-term bullish outlook for Bitcoin, predicting a $1 million price target despite a 47% correction from its 2025 peak. Speaking as Bitcoin trades near $67,000, Trump characterized the digital asset as the premier investment class of the current generation.
Eric Trump, co-founder of World Liberty Financial, has reaffirmed his long-term bullish outlook for Bitcoin, predicting a $1 million price target despite a significant market correction. Speaking to CNBC, the President's son characterized Bitcoin as the 'asset class of this generation' and emphasized its historical 70% average annual growth over the last decade.